Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Burkitt Lymphoma 14Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Follicular 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma 5Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Rhabdomyosarcoma 3Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, B-Cell 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Down Syndrome 3Rhabdomyosarcoma, Alveolar 2Medulloblastoma 2Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, B-Cell, Marginal Zone 2Hepatoblastoma 2Wilms Tumor 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma 1Rhabdoid Tumor 1Pleuropulmonary blastoma 1PRETEXT I Hepatoblastoma 1Osteosarcoma 1Neuroblastoma 1

Interventions

Magnetic Resonance Spectroscopy 2Etoposide 2Doxorubicin 2Cyclophosphamide 2Carboplatin 2Biopsy 2dinutuximab 1Watchful Waiting 1Vincristine 1Transurethral Resection of Bladder 1Topotecan 1Thiotepa 1Temozolomide 1Stem Cell Transplantation 1Specimen Handling 1Radiotherapy 1Radiation 1Proton Therapy 1Platinum 1Observation 1Nuclear Medicine Department, Hospital 1Melphalan 1Leukapheresis 1Isotretinoin 1Irinotecan 1High-Energy Shock Waves 1Hematopoietic Stem Cell Transplantation 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ganglioneuroblastoma × Vincristine × 30 days × Clear all
NCT06172296 2026-05-27

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Recruiting
478 enrolled
CNS

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡